Opaleye Management Inc.
CIK 0001595855
10% Owner
Filings
121
Latest May 29, 2026
Issuers covered
9
Showing
21 of 121
Page 3
Track record
242 of 283 open-market trades scored (86% price coverage) - 41 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 242 | 67% | +8.9% | +6.4% | +85.6% | -40.7% |
| 90 days | 218 | 70% | +16.3% | +23.2% | +156.7% | -285.5% |
| 180 days | 180 | 39% | -3.2% | -17.6% | +469.8% | -174.6% |
| 365 days | 133 | 37% | +23.2% | -17.3% | +429.1% | -90.8% |
Issuers
Companies where Opaleye Management Inc. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| CDXS | Codexis, Inc. | 28 | Dec 15, 2025 |
| HROW | Harrow, Inc. | 21 | Mar 5, 2026 |
| SLGL | Sol-Gel Technologies Ltd. | 17 | May 22, 2026 |
| TARA | Protara Therapeutics, Inc. | 14 | Sep 12, 2024 |
| ACOG | Alpha Cognition Inc. | 13 | May 29, 2026 |
| TCON | Tracon Pharmaceuticals, Inc. | 13 | Nov 14, 2023 |
| SNWV | Sanuwave Health, Inc. | 6 | May 4, 2026 |
| TELA | Tela Bio, Inc. | 5 | Apr 20, 2023 |
| ETON | Eton Pharmaceuticals, Inc. | 4 | Jun 12, 2025 |
All filings
121 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|